Assessment of Statin Treatment for Pulmonary Alveolar Proteinosis without Hypercholesterolemia: A 12-Month Prospective, Longitudinal, and Observational Study

BACKGROUND: Pulmonary alveolar proteinosis (PAP) is a rare disorder which is characterized by the accumulation of excessive surfactant lipids and proteins in alveolar macrophages and alveoli. Oral statin therapy has been reported to be a novel therapy for PAP with hypercholesterolemia. We aimed to e...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Shenyun, Gui, Xianhua, Ding, Jingjing, Yang, Shangwen, Xin, Xiaoyan, Xu, Kaifeng, Xiao, Yonglong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9626205/
https://www.ncbi.nlm.nih.gov/pubmed/36330458
http://dx.doi.org/10.1155/2022/1589660

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9626205/
https://www.ncbi.nlm.nih.gov/pubmed/36330458
http://dx.doi.org/10.1155/2022/1589660

Ejemplares similares